Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses Dominari Holdings Q1 2024 Earnings Widening Losses Reflect Ongoing Investment in Pipeline QRHC Q1 2026 Earnings EPS Misses Estimates by 27 as Stock Edges Up DRDGOLD DRD Q3 Fiscal 2014 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Core Natural Resources CNR Q1 2026 Earnings EPS Beats Estimates by 136 Amid Quiet Market Response L3Harris Q1 2026 Earnings EPS Beat Drives Positive Market Response Despite Limited Revenue Disclosure